This article reviews the development of bifunctional chelates for synthesising 68 Ga
radiopharmaceuticals. It structures the chelates into groups of macrocycles …

Gallium‐68 has the potential to become the technetium‐99m of positron emission
tomography with ideal decay characteristics and a long‐lived parent isotope for generator …

The positron-emitting radionuclide gallium-68 has become increasingly utilised in both
preclinical and clinical settings with positron emission tomography (PET). The synthesis of …

Gallium-68 is a positron-emitting radioisotope that is produced from a 68Ge/68Ga generator.
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …

Abstract In 1964, first 68 Ge/68 Ga radionuclide generators were described. Although the
generator design was by far not adequate to our today's level of chemical …

Gallium-68 (68Ga) is a positron-emitting isotope used for clinical PET imaging of peptide
receptor expression. 68Ga radiopharmaceuticals used in molecular PET imaging consist of …

The construction of the 68 Ge/68 Ga generator has increased application of
radiopharmaceuticals labeled with this isotope in medicine. 68 Ga-PET is widely employed …

Over the past several years, Positron Emission Tomography (PET) imaging agents labeled
with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is …

The most common PET radioisotopes, both in the literature and in clinical practice, are the
cyclotron produced 11C and 18F, giving rise to tracers with minimal chemical changes with …

Abstract Introduction The demand for Gallium-68 (68 Ga) for labelling PET
radiopharmaceuticals has increased over the past few years. 68 Ga is obtained through the …